Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kufner

Showing results (141-150 of 369) with videos related to

Pageof 37
Sort By:
Stroke|March 14, 2015
Infarct volume-based subgroup selection in acute ischemic stroke trialsAnna Kufner, Anke Wouters, Luc Bracoud, et al.
European Journal of Clinical Investigation|January 24, 2024
Aspirin loading and coronary no-reflow after percutaneous coronary intervention in patients with acute myocardial infarctionGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 16, 2024
Left ventricular systolic function after percutaneous coronary intervention: patterns of change and prognosis according to clinical presentation of coronary artery diseaseGjin Ndrepepa, Salvatore Cassese, Michael Joner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 14, 2023
Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y<sub>12</sub> inhibitorsGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2024
Comparative long-term efficacy and safety of two paclitaxel-coated balloons with different coating strategies for the treatment of drug-eluting coronary stent restenosisTobias Koch, Tobias Lenz, Tobias Rheude, et al.
Cancer Immunology, Immunotherapy : CII|March 25, 2005
Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromesS Kufner, R Pelka Fleischer, T Kroell, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosisSebastian Kufner, Jörg Hausleiter, Gjin Ndrepepa, et al.
Journal of Clinical Microbiology|July 13, 2007
Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical useSuzanne M Paule, Donna M Hacek, Bridget Kufner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 15, 2011
Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stentsSebastian Kufner, Steffen Massberg, Michael Dommasch, et al.
Lancet (London, England)|November 25, 2015
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trialsSalvatore Cassese, Robert A Byrne, Gjin Ndrepepa, et al.
Pageof 37

Showing results (141-150 of 369) with videos related to

Sort By:
Pageof 37
Stroke|March 14, 2015
Infarct volume-based subgroup selection in acute ischemic stroke trialsAnna Kufner, Anke Wouters, Luc Bracoud, et al.
European Journal of Clinical Investigation|January 24, 2024
Aspirin loading and coronary no-reflow after percutaneous coronary intervention in patients with acute myocardial infarctionGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 16, 2024
Left ventricular systolic function after percutaneous coronary intervention: patterns of change and prognosis according to clinical presentation of coronary artery diseaseGjin Ndrepepa, Salvatore Cassese, Michael Joner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 14, 2023
Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y<sub>12</sub> inhibitorsGjin Ndrepepa, Salvatore Cassese, Erion Xhepa, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 18, 2024
Comparative long-term efficacy and safety of two paclitaxel-coated balloons with different coating strategies for the treatment of drug-eluting coronary stent restenosisTobias Koch, Tobias Lenz, Tobias Rheude, et al.
Cancer Immunology, Immunotherapy : CII|March 25, 2005
Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromesS Kufner, R Pelka Fleischer, T Kroell, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosisSebastian Kufner, Jörg Hausleiter, Gjin Ndrepepa, et al.
Journal of Clinical Microbiology|July 13, 2007
Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical useSuzanne M Paule, Donna M Hacek, Bridget Kufner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 15, 2011
Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stentsSebastian Kufner, Steffen Massberg, Michael Dommasch, et al.
Lancet (London, England)|November 25, 2015
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trialsSalvatore Cassese, Robert A Byrne, Gjin Ndrepepa, et al.
Pageof 37